ERBB2 and breast carcinoma: During the diagnostic work-up of breast carcinomas, immunohistochemistry (IHC) is the standard method for assessing the expression of estrogen- (ER) and progesterone-receptors (PR), human epidermal growth factor receptor 2 (HER2) as well as of Ki-67 as a marker of tumor cell proliferation.